Design of a MUC1-based cancer vaccine

Biochemical Society Transactions

Volumn 33, Issue 4, 2005, Pages 705-708

  Hanisch, F G ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cancer vaccine; Glycopeptide processing; MHC class I and class II; MUC1; Tumour marker

Indexed keywords

ALANINE; ARGININE; ASPARTIC ACID; CANCER VACCINE; EPITOPE; GLUTAMIC ACID; GLYCAN; GLYCOPEPTIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MUCIN 1; PROLINE; THREONINE; TUMOR MARKER;

ANTIGEN ANTIBODY REACTION; CANCER; CANCER IMMUNIZATION; CANCER RECURRENCE; CELL CLONE; CONFERENCE PAPER; DENDRITE; DRUG DESIGN; HELPER CELL; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; PROTEIN MOTIF;

AMINO ACID SEQUENCE; CA-15-3 ANTIGEN; CANCER VACCINES; DENDRITIC CELLS; DRUG DESIGN; GLYCOPEPTIDES; HLA-D ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; T-LYMPHOCYTES;

EID: 23844526216     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/BST0330705     Document Type: Conference Paper

References (16)

1. Werdelin, O., Meldal, M. and Jensen, T. (2002) Proc. Natl. Acad. Sci. U.S.A. 99, 9611-9613
2. Hiltbold, E.M., Alter, M.D., Ciborowski, P. and Finn, O.J. (1999) Cell. Immunol. 194, 143-149
3. Vlad, A.M., Müller, S., Cudic, M., Paulsen, H., Otvos, L., Hanisch, F.-G. and Finn, O.J. (2002) J. Exp. Med. 196, 1435-1446
4. Hanisch, F.-G., Schwientek, T., von Bergwelt-Baildon, M.S., Schultze, J.L. and Finn, O.J. (2003) Fur. J. Immunol. 33, 3242-3254
5. Thery, C., Boussac, M., Veron, P., Ricciardi-Castagnoli, P., Raposo, G., Garin, J. and Amigorena, S. (2001) J. Immunol. 166, 7309-7318
6. Galli-Stampino, L., Meinjohanns, E., Frische, K., Meldal, M., Jensen, T., Werdelin, O. and Mouritsen, S. (1997) Cancer Res. 57, 3214-3222
7. Jensen, T., Hansen, P., Galli-Stampino, L., Mouritsen, S., Frische, K., Meinjohanns, F., Meldal, M. and Werdelin, O. (1997) J. Immunol. 158, 3769-3778
8. Gad, M., Jensen, T., Gagne, R., Komba, S., Daugaard, S., Kroman, N., Meldal, M. and Werdelin, O. (2003) Eur. J. Immunol. 33, 1624-1632
9. Müller, S., Alving, K., Peter-Katalinic, J., Zachara, N., Gooley, A.A. and Hanisch, F.-G. (1999) J. Biol. Chem. 274, 18165-18172
10. Engelmann, K., Baldus, S.E. and Hanisch, F.-G. (2001) J. Biol. Chem. 276, 27764-27769
11. Fowler, J.C., Teixeira, A.S., Vinall, L.E. and Swallow, D.M. (2003) Hum. Genet. 113, 473-479
12. Von Mensdorff-Pouilly, S., Kinarsky, L., Engelmann, K., Baldus, S.E., Verheijen, R.H., Hollingsworth, M.A., Pisarev, V., Sherman, S. and Hanisch, F.-G. (2005) Glycobiology, in the press
13. Pisarev, V.M., Kinarsky, L., Caffrey, T., Hanisch, F.-G., Sanderson, S., Hollingsworth, M.A. and Sherman, S. (2005) Int. Immunopharmacol. 5, 315-330
14. Dittmann, J., Keller-Matschke, K., Weinschenk, T., Kratt, T., Heck, T., Becker, H.D., Stevanovic, S., Rammensee, H.G. and Gouttefangeas, C. (2004) Cancer Immunol. Immunother., DOI: 10.1007/ s00262-004-0640-7
15. Haurum, J.S., Bjerring Hoier, I., Arsequell, G., Neisig, A., Valencia, G., Zeuthen, J., Neefjes, J. and Elliot, T. (1999) J. Exp. Med. 190, 145-150
16. Apostolopoulos, V., Yuriev, E., Ramsland, P.A., Halton, J., Osinski, C., Li, W., Plebanski, M., Paulsen, H. and McKenzie, I.F.C. (2003) Proc. Natl. Acad. Sci. U.S.A. 100, 15029-15034